BI 2536

This product is for research use only, not for human use. We do not sell to patients.

BI 2536
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$850Check With Us
500mg$1350Check With Us
1g$2025Check With Us

Cat #: V1573 CAS #: 755038-02-9 Purity ≥ 98%

Description: BI2536 (BI-2536; BI 2536) is a novel PLK1/BRD4 dual inhibitor with potential antitumor activity.

References: Steegmaier M, et al. BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo. Current Biology (2007), 17(4), 316-322.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)521.66
Molecular FormulaC28H39N7O3
CAS No.755038-02-9
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 21 mg/mL (40.3 mM)r
Water: <1 mg/mLr
Ethanol: 100 mg/mL (191.7 mM)
Solubility In Vivo30% PEG 400+0.5% Tween 80+5% Propylene glycol: 15mg/mL
SynonymsBI2536; BI-2536 BI 2536
ProtocolIn VitroBeyond the 10-fold concentration range starting at 100 nM, BI2536 causes HeLa cells to accumulate at 4N DNA content, indicating cell cycle arrest in the G2 phase or mitosis. In addition to HeLa cells, BI 2536 potently inhibits the proliferation of a group of 32 human cancer cell lines representing different organ-derived (including breast, colon, lung, pancreatic and prostate, melanoma, and hematopoietic system cancers) and a wide variety of modalities of tumor suppressor or oncogene mutations (including RB1, TP53, PTEN, and KRAS). status). Half of the maximum effective concentration (EC) of this cell group50Values range from 2-25 nM, while BI 100 at a concentration of 2536 nM is usually sufficient to induce complete mitotic arrest. Proliferation of exponentially growing hTERT-RPE1, human umbilical vein endothelial cells (HUVECs), and normal rat kidney (NRK) cells at 12-31 nM EC50 The range of values is blocked, indicating circulation with untransformed cells to BI 2536.
In VivoBI 2536 (40-50 mg/kg, iv) blocks the growth of human cancer xenografts in immunodeficient nu/nu mice. Consecutive cycles of 40-50 mg/kg BI 2536 intravenously once or twice weekly were found to be highly effective in different xenograft models, such as HCT 116 colon cancer with complete tumor suppression with a twice-weekly schedule (treatment versus once-weekly treatment control (T/C) value of 0.3%, T/C value of 16%; Both regimens were well tolerated by clinical signs and the absence of significant weight changes.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.9170 mL9.5848 mL19.1696 mL38.3391 mL
5mM0.3834 mL1.9170 mL3.8339 mL7.6678 mL
10mM0.1917 mL0.9585 mL1.9170 mL3.8339 mL
20mM0.0958 mL0.4792 mL0.9585 mL1.9170 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.